Image pharmaphorum Editor Market Access Around the world in pharma events Stay up to date with key industry meetings and conferences in 2023 Market Access How to solve a problem like DTx in Europe? The promise of digital therapeutics (DTx) has been widely discussed and debated since the term first began to emerge back in the early 2010s. Market Access CSL opens a new R&D facility in Waltham, Massachusetts On March 27th, global biopharma company CSL opened a new R&D facility in Waltham, Massachusetts. Market Access What the HRT is happening with menopause care in the UK? Menopause is a natural process that occurs as women age and marks the end of their reproductive years. Load more results
Market Access Around the world in pharma events Stay up to date with key industry meetings and conferences in 2023
Market Access How to solve a problem like DTx in Europe? The promise of digital therapeutics (DTx) has been widely discussed and debated since the term first began to emerge back in the early 2010s.
Market Access CSL opens a new R&D facility in Waltham, Massachusetts On March 27th, global biopharma company CSL opened a new R&D facility in Waltham, Massachusetts.
Market Access What the HRT is happening with menopause care in the UK? Menopause is a natural process that occurs as women age and marks the end of their reproductive years.
Oncology Advancing the frontiers of cancer diagnostics: Post-ASCO wit... Post-ASCO 2025, Eric Matthews, chief business officer at Caris Life Sciences, discusses advancing the frontier of cancer diagnostics and treatment.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
